首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Metabolism-clinical And Experimental

Metabolism-clinical And Experimental杂志,由W.B. Saunders Ltd出版,于1952年创刊,Monthly,出版语言English,ISSN:0026-0495,E-ISSN:1532-8600。

投稿咨询
Metabolism-clinical And Experimental
Metabolism-clinical And Experimental
Metabolism-clinical And Experimental
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
16.7
CiteScore
21.3
期刊收录
SCI、SCIE

Metabolism-clinical And Experimental(中文译名:《代谢-临床和实验》),ISSN:0026-0495,EISSN:1532-8600,是W.B. Saunders Ltd出版的国际性学术期刊,创刊于1952年,以Monthly形式稳定发行,2026年总发文量约156篇。该刊采用非OA开放访问,学科归属为医学 - 内分泌学与代谢。该刊是医学、内分泌学与代谢领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达16.7,2025年期刊CiteScore为21.3,2025年期刊自引率约4.2%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Metabolism-clinical And Experimental长期聚焦医学、内分泌学与代谢及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、内分泌学与代谢领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USACHINA MAINLAND、Greece、Italy、South Korea、England、GERMANY (FED REP GER)等为核心发文国家与地区;HARVARD UNIVERSITYBETH ISRAEL DEACONESS MEDICAL CENTER、US DEPARTMENT OF VETERANS AFFAIRS、ARISTOTLE UNIVERSITY OF THESSALONIKI、VA BOSTON HEALTHCARE SYSTEM、NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS、CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN RED等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
ENDOCRINOLOGY & METABOLISM 内分泌学与代谢
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 9 / 198

95.7

学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 9 / 198

95.71

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 9 / 193

95.6

学科:ENDOCRINOLOGY & METABOLISM SCIE Q1 9 / 193

95.6


中国学者近期发文

1
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3: A potential target in the development of diabetes and its complication

Author:Jiang, Minmin; An, Xiaofei

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 180, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156621

2
Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integratio

Author:Song, Wei; Nie, Xiaoqian; Zhu, Zhenghong; Wang, Qiong; Zhao, Bingjia; An, Yang; Maimaiti, Adila; Liang, Xiaochun; Zhang, Qian

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 180, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156601

3
SREBP2 links ACSS2-dependent acetyl-CoA biosynthesis to metaboloepigenetic activation of hepatic stellate cells and liver fibrosi

Author:Wang, Yu; Kang, Aoqi; Wang, Shunjie; Yang, Zhen; Liu, Hong; Yue, Linbo; Li, Hao; Wu, Caiyi; Ren, Wenjing; Miao, Xiulian; Li, Zilong; Xu, Yong; Fan, Zhiwen

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156597

4
Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0-

Author:Weng, Bingtao; Wei, Jiahe; Chen, Han; Zhao, Yuyan; Wang, Ningjian; Feng, Hongliang; Ai, Sizhi; Tan, Xiao

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156600

5
Cardiovascular health factors and altered proteomic landscapes in the progression of cardiovascular-kidney-metabolic syndrome: Evidence from multi-cohorts in China, the UK, and the U

Author:Xue, Erxu; Zhao, Jianhui; Chen, Bowen; Ye, Jingyu; Wu, Jingjie; Shao, Jing; Li, Xue; Ye, Zhihong

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156596

6
From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosi

Author:Hu, Xun; Long, Long

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156550

7
Targeting G(3γ subunits in hypothalamic AgRP neurons to treat obesit

Author:Xuan, Ye; Xiong, Xiaoyue; Wang, Xinyu; Wang, Yunqi; Shen, Yun; Zhang, Hong; Zhang, Rong; Chen, Liwei; Zhang, Peng; Zhang, Yi; Hu, Cheng

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156569

8
Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcome

Author:Liu, Lin; Cai, Anping; Wu, Kevin Chun Hei; Xu, Aimin; Lip, Gregory Y. H.; Cheng, Yunjiu; Cheung, Bernard M. Y.; Yiu, Kai-Hang

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156573

9
From mechanism to clinic: A call for actionable strategies to optimize finerenone and SGLT2i complementary therapy in T2DM-related CK

Author:Cui, Yangqing; Zhu, Junyuan; Liu, Yang

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156572

10
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific regio

Author:Zhang, Huai; Chen, Qin-Fen; Lip, Gregory Y. H.; Tilg, Herbert; Valenti, Luca; Somers, Virend K.; Byrne, Christopher D.; Targher, Giovanni; Yang, Wah; Mantzoros, Christos S.; Misra, Anoop; Lonardo, Amedeo; Alswat, Khalid; Sung, Ki-Chul; Muthiah, Mark D.; Zhou, Xiao-Dong; Zheng, Ming-Hua

Journal: METABOLISM-CLINICAL AND EXPERIMENTAL. 2026; Vol. 179, Issue , pp. -. DOI: 10.1016/j.metabol.2026.156575


在线咨询

Metabolism-clinical And Experimental

国际简称:METABOLISM参考译名:代谢-临床和实验

年发文量:156 CiteScore:21.3 是否预警:否 Gold OA文章占比:21.26% 研究类文章占比:83.97%

杂志社联系方式:W B SAUNDERS CO-ELSEVIER INC, 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, USA, PA, 19103-2899

Metabolism-clinical And Experimental